Chemcrux Enterprise is a Specialty Chemical company listed on the BSE SME platform. Chemcrux manufactures import-substitute chemicals that go into manufacture of pharma APIs and pigments. Some of its key products are variants of Chloro Benzoic Acids and Nitro Benzoic Acid. The company’s results for first half of FY20-21 show…
Read More
Growth in the cement industry came back in Jul-Sep’20 quarter, as can be seen from the results of India’s top 2 cement companies. From the investor deck of India’s largest cement company Ultratech Cements: Cement demand rebound in Q2 FY21, with most regions reporting YoY growth. Volume growth was 8%…
Read More
We recorded 96 VC/PE transactions pertaining to the global life sciences sector for Sep 2020, aggregating to a sum of USD 5.6B. USA recorded 52 transactions for with total investment of USD 2.6B. China reported investment of USD 1.5B over 16 VC/PE transactions. China also reported 2 IPOs aggregating to…
Read More
Shares of CL Educate have done well since August 20. CL’s share price was Rs 38 at the end of July. The price rose to Rs 46.5, and is now around Rs 70. This is a smart recovery after the fall CL’s shares had suffered in March due to Covid…
Read More Aug’20 saw China’s lifescience sector receive more VC/PE investment than the USA for the second time ever in terms of monthly recorded amounts, with the first instance being in Apr’20. For Aug’20, China reported USD 2024m of venture capital investments, as compared to USD 1531m recorded by the USA. China…
Read More China’s biotech sector continues to blossom as far as fund raising goes. For 4 months in a row, the sector is witnessing increasing amounts of fund raise. While private deals (VC/PE) led the increase in April and May, in June and July, it is public market fund raising that drove…
Read More
After almost 30 years of moving towards a capitalistic market model, India still has a long way to go. Efficient allocation of capital, risk taking, animal spirits: we don’t truly get this. Banking system is stuck in NPA mess, which the bankruptcy law IBC has not been able to make…
Read More
MMT’s share price hit an all-time low of around USD10 in Apr’20. While it has recovered to around USD15, it is still much less than its normal trading range. While one can blame the share price fall on Covid, but for MMT, this may not be a passing malady. Things…
Read More
We have earlier commented on the sharply accelerated venture capital activity in the biotech sector in China. From around 2-3 deals a month, aggregating maybe USD100m 2-3 years ago, China is now witnessing close to USD1B of venture capital investments in biotech sector on a monthly basis. Keeping company is…
Read More
Furious activity is on around the world to come up with a vaccine for the Covid-19 virus. The stakes are high, not just in human life saving imperative, but also likely financial rewards to the company that is first off the block. The active pipeline, as document by the World…
Read More